Skip Navigation

News & Resources

 

Subscribe to NHLBI Press Releases
January 29, 2016

NHLBI Announces the Recipients of 2016 Orloff Science Awards

The National Heart, Lung, and Blood Institute (NHLBI) is pleased to announce the 2016 Orloff Science Awards, which recognize outstanding achievements in science and the development of novel research tools in the previous year by investigators within NHLBI’s Division of Intramural Research.

January 26, 2016

Asthma prevention study suggests vitamin D supplementation in pregnant women might affect specific immune responses in offspring

WHAT: Providing extra vitamin D to women during pregnancy raised their vitamin D levels without changing recurrent wheezing rates in their offspring by age 3 years, National Institutes of Health-supported research found. However, in these children, who are at high risk for developing asthma, blood tests showed lower levels of specific antibodies related to allergy development, if their mothers took extra vitamin D, according to results appearing in the Journal of the American Medical Association.

Subscribe to NHLBI In The News
February 9, 2016 : Reuters

An NHLBI-supported study sheds new light on patient care at Veterans Affairs (VA) hospitals.  The study compared hospitalizations due to heart attack, heart failure, or pneumonia among older men at VA hospitals to hospitalizations at non-VA hospitals in the United States.  Researchers found that death rates and readmission rates among patients at VA hospitals and patients at non-VA hospitals were very similar.

January 26, 2016 : JAMA

NHLBI-supported study looked at effectiveness of several popular pharmacotherapy smoking cessation therapy options. The study found three options have similar success rates.

February 29, 2016 to March 1, 2016
COPD Town Hall 2016
June 2, 2016 to June 3, 2016
Natcher Conference Center Bathesda, Maryland
Sickle Cell in Focus (SCiF) is an annual two-day intensive and educational conference co-hosted by the National Heart, Lung and Blood Institutes (NHLBI) in Washington, DC and the South Thames Sickle Cell & Thalassaemia Network (STSTN) in London, UK